STOCK TITAN

Varex Imaging (VREX) CFO details RSU vesting, tax sale and new grant

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Varex Imaging Corp's Chief Financial Officer reported multiple equity transactions in company stock. On 12/10/2025, restricted stock units converted into 7,063 and 13,966 shares of common stock, consistent with the one-for-one RSU terms. To cover tax obligations, 5,227 shares were disposed of at $11.7 per share, leaving 106,891 shares of common stock directly owned.

The report also shows a new grant of 58,333 restricted stock units, scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, along with earlier RSU awards that continue to vest on their original schedules.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maheshwari Shubham

(Last) (First) (Middle)
1678 S. PIONEER ROAD

(Street)
SALT LAKE CITY UT 84104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/10/2025 M 7,063 A (1) 98,152(2) D
Common Stock 12/10/2025 M 13,966 A (1) 112,118 D
Common Stock 12/10/2025 F 5,227 D $11.7 106,891 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 12/10/2025 M 7,063 (3) (3) Common Stock 7,063 $0 0 D
Restricted Stock Units (1) 12/10/2025 M 13,966 (4) (4) Common Stock 13,966 $0 13,966 D
Restricted Stock Units (5) 12/10/2025 A 58,333 (5) (5) Common Stock 58,333 $0 58,333 D
Explanation of Responses:
1. Each Restricted Stock Unit converts into common stock on a one-for-one basis.
2. Includes 101 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.
3. These Restricted Stock Units granted on February 15, 2021 vested 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date.
4. These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.
5. These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.
Remarks:
/s/ Shubham Maheshwari 12/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did Varex Imaging Corp (VREX) disclose?

The filing shows the Chief Financial Officer acquired 7,063 and 13,966 shares of Varex Imaging Corp common stock on 12/10/2025 through restricted stock units, and disposed of 5,227 shares at $11.7 per share to satisfy tax obligations.

Who is the reporting person in this Varex Imaging Corp (VREX) insider transaction?

The reporting person is Shubham Maheshwari, who is listed as an officer of Varex Imaging Corp with the title Chief Financial Officer.

How many Varex Imaging Corp (VREX) shares does the CFO own after these transactions?

After the reported transactions on 12/10/2025, the Chief Financial Officer beneficially owns 106,891 shares of Varex Imaging Corp common stock in direct ownership.

What new restricted stock units were granted to the VREX CFO?

On 12/10/2025, the CFO received a new award of 58,333 restricted stock units, each convertible into one share of common stock, scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029.

What are the vesting terms of the earlier restricted stock unit awards reported by VREX?

Restricted stock units granted on February 15, 2021 vested 50% on February 15, 2023 and 50% on February 15, 2025. Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027, and vested shares are delivered on each vest date.

Does the VREX CFO’s reported share count include employee stock purchase plan shares?

Yes. The beneficial ownership figure includes 101 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last filing by the reporting person.

Varex Imaging Corp

NASDAQ:VREX

VREX Rankings

VREX Latest News

VREX Latest SEC Filings

VREX Stock Data

494.44M
40.94M
1.66%
95.51%
2.25%
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY